Zobrazeno 1 - 10
of 13
pro vyhledávání: '"P J, Kostyniak"'
Autor:
P J, Kostyniak
Publikováno v:
The New York state dental journal. 64(4)
Mercury has been used for centuries for medical, chemical, metallurgical and electrical applications. It is an element of mystery, which in its metallic form is an enticing silvery liquid that can be as fascinating as it is dangerous. Its use in dent
Publikováno v:
Journal of biochemical and molecular toxicology. 12(1)
Administration to rats of 1,3-difluoro-2-propanol (100 mg kg-1 body weight), the major ingredient of the pesticide gliftor, resulted in accumulation of citrate in the kidney after a 3 hour lag phase. 1,3-Difluoro-2-propanol was found to be metabolize
Publikováno v:
Toxicology and applied pharmacology. 112(2)
The present study further developed primary cultures of rabbit renal proximal tubule cells (RPTC) as an in vitro model to study chemical-induced toxicity by investigating the comparative cytotoxicity of mercuric chloride (HgCl2) and methyl mercury ch
Publikováno v:
Journal of Biochemical and Molecular Toxicology. 12:133-133
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 207(1)
Autor:
P J, Kostyniak
Publikováno v:
Bulletin of the 8th District Dental Society. 18(3)
Publikováno v:
Neurotoxicology. 10(2)
The neurotoxicity associated with chronic exposure to hexachlorophene (HCP) was evaluated by measuring the activity of seven cell specific marker enzymes in brain and by comparing these measurements to morphological changes analyzed by light microsco
Autor:
A I, Soiefer, P J, Kostyniak
Publikováno v:
The Journal of biological chemistry. 259(17)
Fluoraocetate-specific defluorinase, an enzyme which catalyzes the release of fluoride ion from the rodenticide fluoroacetate, has been purified 347-fold from mouse liver cytosol and shown to be distinct from multiple cationic and anionic glutathione
Autor:
K M, Mulder, P J, Kostyniak
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 234(1)
The gamma-GTP inhibitor L-(alpha S,5S)-alpha-amino-3-chloror-4,5-dihydro-5-isoxazoleacetic acid (AT-125) was administered to CBA/J mice pretreated with 203Hg-methylmercury (MM) (0.5 mg/kg) to determine whether increasing urinary GS in this strain wou
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 203(2)
An extracorporeal regional complexing hemodialysis procedure is described which has been successfully applied for the enhancement of removal of methylmercury in the dog. The procedure utilizes the extracorporeal addition of cysteine to arterial blood